POSPISILOVA, S., I. MALIK, J. CURILLOVA, H. MICHNOVA, L. CERNA, Tereza PADRTOVÁ, J. HOSEK, D. PECHER, A. CIZEK a J. JAMPILEK. Insight into antimicrobial activity of substituted phenylcarbamoyloxypiperazinylpropanols. Bioorganic Chemistry. SAN DIEGO: ACADEMIC PRESS INC ELSEVIER SCIENCE, 2020, roč. 102, SEP 2020, s. 1-13. ISSN 0045-2068. Dostupné z: https://dx.doi.org/10.1016/j.bioorg.2020.104060.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Insight into antimicrobial activity of substituted phenylcarbamoyloxypiperazinylpropanols
Autoři POSPISILOVA, S., I. MALIK, J. CURILLOVA, H. MICHNOVA, L. CERNA, Tereza PADRTOVÁ (203 Česká republika, domácí), J. HOSEK, D. PECHER, A. CIZEK a J. JAMPILEK.
Vydání Bioorganic Chemistry, SAN DIEGO, ACADEMIC PRESS INC ELSEVIER SCIENCE, 2020, 0045-2068.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30104 Pharmacology and pharmacy
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 5.275
Kód RIV RIV/00216224:14160/20:00118183
Organizační jednotka Farmaceutická fakulta
Doi http://dx.doi.org/10.1016/j.bioorg.2020.104060
UT WoS 000567809600011
Klíčová slova anglicky Piperazine; Carbamate; Antibacterial; Antimycobacterial; Synergy; Antibiofilm activity; Antiproliferative effect
Štítky rivok, ÚChL
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: PharmDr. Jitka Michlíčková, učo 151288. Změněno: 16. 2. 2021 14:33.
Anotace
3-[4-(Substituted)phenyl-/4-(diphenylmethyl)phenylpiperazin-1-yl]-2-hydroxypropyl-1-[(substituted)phenyl] carbamates and their salts with hydrochloric acid were synthesized, characterized, and tested in vitro against Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 29212 as reference and quality control strains, against three methicillin-resistant isolates of S. aureus, and three isolates of vancomycin-resistant E. faecalis. All the compounds were evaluated against Mycobacterium tuberculosis H37Ra/ATCC 25177, M. kansasii DSM 44162, and M. smegmatis ATCC 700084. All of the tested compounds demonstrated very good activity against all the tested strains/isolates comparable with or better than that of clinically used drugs (ampicillin, ciprofloxacin, vancomycin, isoniazid). 1-[{(3-Trifluoromethyl)phenyl}carbamoyloxy-2-hydroxypropyl]-4-(3,4-dichlorophenyl)piperazin-1-ium chloride demonstrated the highest potency against all the tested strains/isolates (MICs ranged from 3.78 to 30.2 mu M), and 1-[{(3-trifluoromethyl)phenyl}carbamoyloxy-2-hydroxypropyl]-4-(diphenylmethyl)piperazin-1-ium chloride was the most effective against all the screened mycobacterial strains (MICs ranged from 3.64 to 14.5 mu M). All the investigated derivatives had strong antibiofilm activity against S. aureus ATCC 29123 and a synergistic or additive effect with gentamicin against isolates of E. faecalis with both intrinsic and acquired resistance to gentamicin. The screening of the cytotoxicity of the compounds was performed using human monocytic leukemia THP-1 cells. The IC50 values of the most effective compounds ranged from ca. 2.8 to 7.3 mu M; thus, it can be stated that the antimicrobial effect is closely connected with their cytotoxicity. These observations disqualify these compounds from further development as antimicrobial agents, but they can be considered potential multi-target drugs with a preferred anticancer effect with good water solubility and additional anti-infectious activity.
VytisknoutZobrazeno: 27. 4. 2024 03:59